Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Pediatrics
Volume 2018, Article ID 4375434, 5 pages
https://doi.org/10.1155/2018/4375434
Case Report

Lysosomal Acid Lipase Deficiency: Report of Five Cases across the Age Spectrum

1Reference Center for Inborn Errors of Metabolism (CREIM), Department of Pediatrics, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil
2Laboratory for Inborn Errors of Metabolism, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil
3Department of Pathology, Universidade Federal de São Paulo (UNIFESP), São Paulo, SP, Brazil

Correspondence should be addressed to Marco Antonio Curiati; moc.liamg@itairucocram

Received 10 July 2017; Revised 15 September 2017; Accepted 2 November 2017; Published 21 January 2018

Academic Editor: Nur Arslan

Copyright © 2018 Marco Antonio Curiati et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. A. Grabowski, L. Charnas, and H. Du, “Lysosomal acid lipase deficiencies: the Wolman disease/cholesteryl ester storage disease spectrum,” in Metabolic and Molecular Bases of Inherited Disease, D. Valle, A. L. Beaudet, B. Vogelstein et al., Eds., McGraw-Hill, New York, NY, USA, 8th edition, 2012. View at Google Scholar
  2. A. Abramov, S. Schorr, and M. Wolman, “Generalized xanthomatosis with calcified adrenals,” A.M.A. Journal of Diseases of Children, vol. 91, no. 3, pp. 282–286, 1956. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Pericleous, C. Kelly, T. Wang, C. Livingstone, and A. Ala, “Wolman’s disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency,” The Lancet Gastroenterology and Hepatology, vol. 2, no. 9, pp. 670–679, 2017. View at Publisher · View at Google Scholar
  4. D. S. Fredrickson, “Newly recognized disorders of cholesterol metabolism,” Annals of Internal Medicine, vol. 58, no. 4, p. 718, 1963. View at Publisher · View at Google Scholar
  5. M. Wolman, V. V. Sterk, S. Gatt, and M. Frenkel, “Primary familial xanthomatosis with involvement and calcification of the adrenals. Report of two more cases in siblings of a previously described infant,” Pediatrics, vol. 28, pp. 742–757, 1961. View at Google Scholar
  6. W. C. Marshall, B. G. Ockenden, A. S. Fosbrooke, and J. N. Cumings, “Wolman’s disease: a rare lipidosis with adrenal calcification,” Archives of Disease in Childhood, vol. 44, no. 235, pp. 331–341, 1969. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Elleder, A. Chlumska, J. Hyanek et al., “Subclinical course of cholesteryl ester storage disease in an adult with hypercholesterolemia, accelerated atherosclerosis, and liver cancer,” Journal of Hepatology, vol. 32, no. 3, pp. 528–534, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Sporea, A. Popescu, and R. Sirli, “Why, who and how should perform liver biopsy in chronic liver diseases,” World Journal of Gastroenterology (WJG), vol. 14, no. 21, pp. 3396–3402, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Santillán-Hernández, E. Almanza-Miranda, W. W. Xin et al., “Novel LIPA mutations in Mexican siblings with lysosomal acid lipase deficiency,” World Journal of Gastroenterology (WJG), vol. 21, no. 3, pp. 1001–1008, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Boldrini, R. Devito, R. Biselli, M. Filocamo, and C. Bosman, “Wolman disease and cholesteryl ester storage disease diagnosed by histological and ultrastructural examination of intestinal and liver biopsy,” Pathology-Research and Practice, vol. 200, no. 3, pp. 231–240, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. D. L. Bernstein, H. Hulkova, M. G. Bialer, and R. J. Desnick, “Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease,” Journal of Hepatology, vol. 58, no. 6, pp. 1230–1243, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Hamilton, I. Jones, R. Srivastava, and P. Galloway, “A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor Lalistat 2,” Clinica Chimica Acta, vol. 413, no. 15-16, pp. 1207–1210, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Taurisano, A. Maiorana, F. De Benedetti, C. Dionisi-Vici, R. Boldrini, and F. Deodato, “Wolman disease associated with hemophagocytic lymphohistiocytosis: attempts for an explanation,” European Journal of Pediatrics, vol. 173, no. 10, pp. 1391–1394, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. L. Hautekeete, C. Degott, and J. P. Benhamou, “Microvesicular steatosis of the liver,” Acta Clinica Belgica, vol. 45, no. 5, pp. 311–326, 1990. View at Publisher · View at Google Scholar
  15. S. Tandra, M. M. Yeh, E. M. Brunt et al., “Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease,” Journal of Hepatology, vol. 55, no. 3, pp. 654–659, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Saito, K. Ohno, T. Suzuki, and H. Sakuraba, “Structural bases of Wolman disease and cholesteryl ester storage disease,” Molecular Genetics and Metabolism, vol. 105, no. 2, pp. 244–248, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Hoeg, S. J. Demosky Jr., O. H. Pescovitz, and H. B. Brewer Jr., “Cholesteryl ester storage disease and Wolman disease: phenotypic variants of lysosomal acid cholesteryl ester hydrolase deficiency,” American Journal of Human Genetics, vol. 36, no. 6, pp. 1190–1203, 1984. View at Google Scholar
  18. Z. Reiner, O. Guardamagna, D. Nair et al., “Lysosomal acid lipase deficiency–an under-recognized cause of dyslipidaemia and liver dysfunction,” Atherosclerosis, vol. 235, no. 1, pp. 21–30, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Balwani, C. Breen, G. M. Enns et al., “Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease,” Hepatology, vol. 58, no. 3, pp. 950–957, 2013. View at Publisher · View at Google Scholar · View at Scopus